Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 9/20 | 1.00 |
| ▸ | CA12 | O43570 | 4/20 | 1.00 |
| ▸ | CA1 | P00915 | 4/20 | 1.00 |
| ▸ | CA6 | P23280 | 4/20 | 1.00 |
| ▸ | CA7 | P43166 | 4/20 | 1.00 |
| ▸ | CA9 | Q16790 | 4/20 | 1.00 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 1.00 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 1.00 |
| ▸ | CA2 | P00918 | 3/20 | 1.00 |
| ▸ | CA5A | P35218 | 3/20 | 1.00 |
| ▸ | CA4 | P22748 | 3/20 | 1.00 |
| ▸ | MAOA | P21397 | 2/20 | 0.69 |
| ▸ | GPR35 | Q9HC97 | 4/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.67 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.67 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.67 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.67 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1368129 | 0.88 | MAOB (0.79) | MAOBCA12CA1CA6CA7 | |
| SCHEMBL14642321 | 0.87 | MAOB (0.77) | MAOBCA12CA1CA6CA7 | |
| SCHEMBL10305750 | 0.87 | CA12 (0.77) | MAOBCA12CA1CA6CA7 | |
| SCHEMBL9989055 | 0.85 | MAOB (0.74) | MAOBCA12CA1CA6CA7 | |
| SCHEMBL18589240 | 0.83 | MAOB (0.70) | MAOBCA12CA1CA6CA7 | |
| SCHEMBL28703856 | 0.81 | MAOB (0.68) | MAOBCA12CA1CA6CA7 | |
| SCHEMBL31457861 | 0.81 | MAOB (0.68) | MAOBCA12CA1CA6CA7 | |
| SCHEMBL29785071 | 0.81 | MAOA (1.00) | MAOBCA12CA1CA6CA7 | |
| SCHEMBL11266285 | 0.81 | MAOA (0.71) | MAOBCA12CA1CA6CA7 | |
| SCHEMBL979779 | 0.81 | MAOA (1.00) | MAOBCA12CA1CA6CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8968711-B2 | Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process | L'OREAL (FR) | 2015-03-03 | — | — | US | claimed |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | L'OREAL (FR) | 2010-10-28 | — | — | US | claimed |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2010-09-23 | — | — | US | claimed |
| CN-119192113-A | Pleuromutilin derivative and preparation method and application thereof | 西华大学 | 2024-12-27 | — | — | CN | disclosed |
| CN-116693487-A | Coumarin-based thioester photoinitiator suitable for photopolymerization and preparation method thereof | 北京化工大学 | 2023-09-05 | — | — | CN | disclosed |
| WO-2023094734-A1 | LIGANDS SPECIFICALLY TARGETING VESICULAR GLUTAMATE TRANSPORTERS FOR SUPER-RESOLUTION IMAGING | Sorbonne Université (FR) | 2023-06-01 | — | — | WO | disclosed |
| CN-111455005-B | Method for synthesizing coumarin-3-carboxylic acid-6' -O-D-sucrose ester derivative on line enzymatically based on flow chemistry | 浙江农林大学 | 2023-05-05 | — | — | CN | disclosed |
| CN-110804045-B | Coumarin hybrid pyridone amide derivative with potential anti-AD activity and preparation method and application thereof | 浙江工业大学 | 2021-07-27 | — | — | CN | disclosed |
| CN-107445933-B | 3-coumarin formic acid compound and application thereof in preparation of phytopathogen antibacterial agent | 西北农林科技大学 | 2021-03-23 | — | — | CN | disclosed |
| CN-111455005-A | Method for synthesizing coumarin-3-carboxylic acid-6' -O-D-sucrose ester derivative through on-line enzymatic synthesis based on flow chemistry | 浙江农林大学 | 2020-07-28 | — | — | CN | disclosed |
| CN-110804045-A | Coumarin hybrid pyridone amide derivative with potential anti-AD activity and preparation method and application thereof | 浙江工业大学 | 2020-02-18 | — | — | CN | disclosed |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | L'OREAL (FR) | 2010-10-28 | — | — | US | disclosed |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2010-09-23 | — | — | US | disclosed |
| US-20090028807-A1 | COMPOSITION COMPRISING A POLYCONDENSATE, METHOD OF TREATMENT, POLYCONDENSATE, AND METHOD OF PREPARATION | L'OREAL (FR) | 2009-01-29 | — | — | US | disclosed |
| US-6355658-B1 | COUMARIN ESTERS WITH ETHER GROUPS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2002-03-12 | — | — | US | disclosed |
| EP-0988298-A1 | COUMARIN DERIVATIVES, METHODS OF PREPARATION AND APPLICATION AS MEDICINES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2000-03-29 | — | — | EP | disclosed |
| WO-1998055472-A1 | COUMARIN DERIVATIVES, METHODS OF PREPARATION AND APPLICATION AS MEDICINES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 1998-12-10 | — | — | WO | disclosed |
| US-4343938-A | 7-[Dα-(Coumarin-3-carboxamido)arylacetamido]-cephalosporanic acids or salts | AMERICAN CYANAMID COMPANY (US) | 1982-08-10 | — | — | US | disclosed |
| US-4317774-A | 6-[D-α-(Coumarin-3-carboxamido)arylacetamido]-penicillanic acids or salts | AMERICAN CYANAMID COMPANY (US) | 1982-03-02 | — | — | US | disclosed |
| US-4159268-A | ANTIBIOTICS, MICROBIOCIDES | AMERICAN CYANAMID COMPANY (US) | 1979-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | CUTA, SUCLG1, KRT18 | MAOB 1498/4885CA12 15/4885CA1 185/4885 |
| US-20090028807-A1 | COMPOSITION COMPRISING A POLYCONDENSATE, METHOD OF TREATMENT, POLYCONDENSATE, AND METHOD OF PREPARATION | CUTA, SYMPK, TPRKB | MAOB 3522/4885CA12 3507/4885CA1 4550/4885 |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | ACMSD, CUTA, PCCA | MAOB 3151/4885CA12 403/4885CA1 1334/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.